Foundry Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-33,836
| Closed | -$673K | – | 407 |
|
|
2019
Q1 | $673K | Buy |
33,836
+9,079
| +37% | +$181K | 0.03% | 334 |
|
|
2018
Q4 | $327K | Buy |
24,757
+3,376
| +16% | +$44.6K | 0.01% | 359 |
|
|
2018
Q3 | $786K | Sell |
21,381
-34
| -0.2% | -$1.25K | 0.03% | 336 |
|
|
2018
Q2 | $750K | Sell |
21,415
-1,391
| -6% | -$48.7K | 0.03% | 333 |
|
|
2018
Q1 | $1.06M | Buy |
22,806
+5,446
| +31% | +$253K | 0.05% | 322 |
|
|
2017
Q4 | $651K | Sell |
17,360
-4,789
| -22% | -$180K | 0.03% | 329 |
|
|
2017
Q3 | $1.18M | Sell |
22,149
-64
| -0.3% | -$3.41K | 0.05% | 315 |
|
|
2017
Q2 | $1.27M | Sell |
22,213
-502
| -2% | -$28.6K | 0.05% | 324 |
|
|
2017
Q1 | $1.22M | Buy |
22,715
+7,225
| +47% | +$388K | 0.05% | 336 |
|
|
2016
Q4 | $883K | Buy |
+15,490
| New | +$883K | 0.04% | 353 |
|